Zenith Drugs (NSE:ZENITHDRUG) ROE % Adjusted to Book Value: 5.40% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:ZENITHDRUG Zenith Drugs Ltd NSE:ZENITHDRUG
36 GF Score
Price ₹50.10
! 8 Warning Signs
View Full Analysis

What is Zenith Drugs ROE % Adjusted to Book Value?

Zenith Drugs NSE:ZENITHDRUG -4.48% 36 ROE % Adjusted to Book Value is 5.40% as of Mar. 2026. GuruFocus rates NSE:ZENITHDRUG with a GF Score™ of 36/100. The stock has 8 warning signs investors should review.

Zenith Drugs's ROE % for the quarter that ended in Mar. 2026 was 4.43%. Zenith Drugs's PB Ratio for the quarter that ended in Mar. 2026 was 0.82. Zenith Drugs's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was 5.40%.

Zenith Drugs ROE % Adjusted to Book Value Related Terms

Zenith Drugs ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Zenith Drugs's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zenith Drugs ROE % Adjusted to Book Value Chart

Zenith Drugs Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
ROE % Adjusted to Book Value
Get a 7-Day Free Trial 0.00 0.00 13.79 6.15 6.74

Zenith Drugs Semi-Annual Data
Mar21 Mar22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only 11.25 0.00 2.35 4.16 5.40

NSE:ZENITHDRUG vs ZTS, UTHR: ROE % Adjusted to Book Value Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Zenith Drugs's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zenith Drugs ROE % Adjusted to Book Value vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zenith Drugs's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Zenith Drugs's ROE % Adjusted to Book Value falls into.


NSE:ZENITHDRUG
36GF Score
Zenith Drugs Ltd NSE:ZENITHDRUG
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zenith Drugs ROE % Adjusted to Book Value Calculation

Zenith Drugs's ROE % Adjusted to Book Value for the fiscal year that ended in Mar. 2026 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=5.53% / 0.82
=6.74%

Zenith Drugs's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=4.43% / 0.82
=5.40%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of 5.40% mean?
Zenith Drugs (NSE:ZENITHDRUG) has a ROE % Adjusted to Book Value of 5.40% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Zenith Drugs and its competitors.
Is Zenith Drugs' ROE % Adjusted to Book Value too high?
Zenith Drugs' current ROE % Adjusted to Book Value is 5.40%. Overall, Zenith Drugs has a GF Score™ of 36/100, reflecting its overall financial health beyond just this single metric.
How does Zenith Drugs' ROE % Adjusted to Book Value compare to ZTS and UTHR?
Zenith Drugs' ROE % Adjusted to Book Value of 5.40% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Drug Manufacturers company?
A good ROE % Adjusted to Book Value depends on the Drug Manufacturers industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Zenith Drugs and its competitors. Zenith Drugs's current ROE % Adjusted to Book Value is 5.40%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zenith Drugs stock overvalued right now?
Zenith Drugs (NSE:ZENITHDRUG) has a current ROE % Adjusted to Book Value of 5.40%. The current ROE % Adjusted to Book Value is 5.40%. Zenith Drugs' overall GF Score™ is 36/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Zenith Drugs (NSE:ZENITHDRUG), the current ROE % Adjusted to Book Value is 5.40% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Zenith Drugs Business Description

Address K. No. 72/5, Village Muradpura, Depalpur, Indore, MP, IND, 453001
Zenith Drugs Ltd is a pharmaceutical manufacturing and trading company. It offers a wide range of formulations in various forms such as ORS Powder, Liquid Orals, Ointments, Liquid Externals, Creams, Gels, Capsules, and Tablets. It is also into Generic Medicines.
36GF Score

Get the complete analysis for NSE:ZENITHDRUG

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹50.10
Price